Labcorp Drug Development - Strategic SWOT Analysis Review

Labcorp Drug Development - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

• Business description - A detailed description of the company’s operations and business divisions.
• Corporate strategy - The summarization of the company’s business strategy.
• SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history - Progression of key events associated with the company.
• Major products and services - A list of major products, services and brands of the company.
• Key competitors - A list of key competitors to the company.
• Key employees - A list of the key executives of the company.
• Executive biographies - A brief summary of the executives’ employment history.
• Key operational heads - A list of personnel heading key departments/functions.
• Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.

Highlights

Labcorp Drug Development (Labcorp), formerly known as Covance Inc, is a contract research company that offers drug development and manufacturing services. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, informatics, clinical testing, clinical development, commercialization, and manufacturing support, among others. It offers solutions in various therapeutic areas such as cardiovascular; diabetes, endocrinology and nephrology; immuno-oncology; infectious diseases; inflammation; neuroscience; non-alcoholic steatohepatitis; oncology; rare disease and orphan drugs; and pediatrics. Labcorp also offers laboratory testing services for agrochemical and chemical industries. It operates in the US, Europe, Latin America, Africa, and Asia-Pacific. The company operates as a subsidiary of Laboratory Corp of America Holdings. Labcorp is headquartered in Burlington, North Carolina, the US.

Labcorp Drug Development Key Recent Developments

• Jul 27, 2023: Labcorp Announces 2023 Second Quarter Results
• Jul 11, 2023: Labcorp and Legacy Health Agree to Comprehensive Laboratory Relationship
• May 16, 2023: Resilience Enters Into Strategic Collaboration with Labcorp to Accelerate Cell and Gene Therapies
• Jan 25, 2023: VieCure and Labcorp collaboration will improve clinical workflow, increasing patient access to genomic testing

Reasons to Buy

• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
• Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
• Understand and respond to your competitors’ business structure and strategies with the publisher's detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
• Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.